Genetic Medicine

Four Vanderbilt graduate students, faculty advisers named to Howard Hughes Medical Institute Gilliam Fellows Program for their leadership in science and commitment to advancing equity and inclusion in science. Read More

A massive worldwide collaboration including researchers from Vanderbilt University Medical Center (VUMC) has identified several genetic factors associated with SARS-CoV-2 infection and severe COVID-19 illness. Read More

Fluid build-up in the brain — hydrocephalus — increases pressure and risk for brain damage; Vanderbilt researchers have now identified genes and signaling pathways associated with the condition. Read More

Electronic health records and biobanks can be effectively combined to detect and study Mendelian diseases such as cystic fibrosis. Read More

An international research team has discovered a new genetic syndrome caused by mutation of a single gene and named it CATIFA, an acronym for its core symptoms. Read More

VUMC's Eric Gamazon has received a Genomic Innovator Award from the National Human Genome Research Institute, part of the NIH. Read More

Symptoms of schizophrenia and bipolar disorder, including psychosis, depression and manic behavior, have both shared and distinguishing genetic factors, an international consortium led by researchers from Vanderbilt University and Virginia Commonwealth University is reporting. Read More

Eric Gamazon, PhD, research instructor in the Division of Genetic Medicine at Vanderbilt University School of Medicine, is spending part of the academic year at Cambridge University in England as one of 40 Clare Hall Visiting Fellows. Read More

Nancy Cox, Ph.D., founding director of the Vanderbilt Genetics Institute, will deliver the next Flexner Discovery Lecture on Thursday, Dec. 17. Read More

New findings suggest a previously unrecognized role for the Sox10 transcription factor in Hirschsprung’s disease, and may lead to improved diagnostic and therapeutic approaches for this disease. Read More

A team led by Vanderbilt University investigators has discovered two new genes — both coding for the signaling protein calmodulin — associated with severe early-onset disorders of heart rhythm. Read More

A rare, inherited mutation confers an eightfold increased risk of prostate cancer, a recent study shows. Read More

A study led by Vanderbilt-Ingram Cancer Center investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn’t effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer. Read More

The Vanderbilt Digestive Disease Research Center celebrates its 10th anniversary this year with a second five-year renewal of its federal research grant. Read More

The discovery of a new gene that can influence a person's risk for developing epilepsy could improve diagnostic tools and open the door for new therapies. Read More